Skip to main content Skip to section navigation Skip to footer
  • About Us
      Company Overview
      Team
      Careers
  • Gene Therapies
      Our Approach
      Publications & Presentations
  • Patients
      Patients & Families
      Patient Spotlight
  • Pipeline & Programs
      OPGx-BEST1
      OPGx-LCA5
      Preclinical
  • Investors
  • Contact Us
Skip to main content Skip to section navigation Skip to footer
Opus Genetics, Inc. IR Overview
  • Overview
  • Press Releases
  • Events
  • Presentations
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • Governance
    • Overview
    • Leadership Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • IR Contact
    • Email Alerts
    • Investor FAQs
    • RSS News Feed
  • Back to Corporate Site

Section 16 Filings

Investors

  • Overview
  • Press Releases
  • Events
  • Presentations
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • Governance
    • Overview
    • Leadership Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • IR Contact
    • Email Alerts
    • Investor FAQs
    • RSS News Feed
  • SEC Filings

  • All SEC Filings
  • Annual Reports
  • Quarterly Reports
  • Section 16 Filings
SEC Filings
Date Form Description XBRL Pages
04/25/08 4 Form 4: Statement of changes in beneficial ownership of securities 2
04/23/08 4 Form 4: Statement of changes in beneficial ownership of securities 2
04/16/08 4 Form 4: Statement of changes in beneficial ownership of securities 2
04/15/08 4 Form 4: Statement of changes in beneficial ownership of securities 2
04/10/08 4 Form 4: Statement of changes in beneficial ownership of securities 2
12/26/07 4 Form 4: Statement of changes in beneficial ownership of securities 1
11/30/07 3 Form 3: Initial statement of beneficial ownership of securities 2
06/13/07 4 Form 4: Statement of changes in beneficial ownership of securities 1
06/13/07 4 Form 4: Statement of changes in beneficial ownership of securities 2
06/13/07 4 Form 4: Statement of changes in beneficial ownership of securities 1
rss_feed Filing RSS
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Next Pagearrow_forward
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • accessibilityAccessibility Statement
Opus Genetics, Inc. home Opus Genetics on LinkedIn

Sign up to receive our newsletter

By providing your email address, you consent to receive messages from Opus Genetics. View our Privacy Policy.

  • Gene Therapies
  • Patients & Families
  • Pipeline
  • About Us
  • Careers
  • Contact Us
  • Investors
© 2026 Opus Genetics, Inc.
  • Cookie Policy
  • Privacy Statement
Site by BKW